This activity is expired and is no longer available for CME credit.


Intravitreal Aflibercept for Diabetic Macular Edema

Author(s)/Faculty: Quan Dong Nguyen, MD, MSc
Release Date: 4/18/2016Expiration Date: 4/3/2019
Credit Type: CMENumber of Credits: 0
Content Type: LectureProvider:
A leading cause of blindness in the United States, diabetic retinopathy is especially challenging because it is generally asymptomatic, even as the vision-threatening disease process progresses. Anti-VEGF agents have been established as effective treatment options diabetic macular edema (DME). This CME activity discusses the analysis by baseline demographics and systemic disease characteristics from the VIVID and the VISTA studies with aflibercept for DME.